Abstract
When considering methylxanthines and human health, it must be recognized that in many countries most caffeine is consumed as coffee. This is further confounded by the fact that coffee contains many bioactive substances in addition to caffeine; it is rich in phenols (quinides, chlorogenic acid, and lactones) and also has diterpenes (fatty acid esters), potassium, niacin, magnesium, and the vitamin B3 precursor trigonelline. There is a paradox as consumption of either caffeine or caffeinated coffee results in a marked insulin resistance and yet habitual coffee consumption has repeatedly been reported to markedly reduce the risk for type 2 diabetes. There is strong evidence that caffeine reduces insulin sensitivity in skeletal muscle and this may be due to a combination of direct antagonism of A1 receptors and indirectly β-adrenergic stimulation as a result of increased sympathetic activity. Caffeine may also induce reduced hepatic glucose output. With the exception of bone mineral, there is little evidence that caffeine impacts negatively on other health issues. Coffee does not increase the risk of cardiovascular diseases or cancers and there is some evidence suggesting a positive relationship for the former and for some cancers, particularly hepatic cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AUC:
-
Area under the curve
- cAMP:
-
Cyclic AMP
- CGA:
-
Chlorogenic acid
- CNS:
-
Central nervous system
- CVD:
-
Cardiovascular disease
- CYP1A2:
-
Cytochrome P450 1A2
- FFA:
-
Free fatty acid
- GIP:
-
Glucose-dependent insulinotropic polypeptide
- GLP-1:
-
Glucagon-like peptide-1
- ISI:
-
Insulin sensitivity index
- OGTT:
-
Oral glucose tolerance test
- SNS:
-
Sympathetic nervous system
- T2D:
-
Type 2 diabetes
References
Acheson KJ, Zahorska-Markiewick B et al (1980) Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 33(5):989–997
Acheson KJ, Gremaud G et al (2004) Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr 79(1):40–46
Adeney KL, Williams MA et al (2007) Coffee consumption and the risk of gestational diabetes mellitus. Acta Obstet Gynecol Scand 86(2):161–166, Abstract
Agardh EE, Carlsson S et al (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255(6):645–652
Ahmed HN, Levitan E et al (2009) Coffee consumption and risk of heart failure in men: an analysis from the cohort of Swedish men. Am Heart J 158:667–672
Andrade-Cetto A, Wiedenfeld H (2001) Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 78(2–3):145–149
Antoniade C, Antonopoulos AS et al (2009) Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30(1):6–15
Arciero PJ, Gardner AW et al (1995) Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 268(6Pt1):E1192–E1198
Arion WJ, Canfield WK et al (1997) Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339(2):315–322
Ascherio A, Zhang SM et al (2001) Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Ann Neurol 50(1):56–63
Ascherio A, Chen H et al (2003) Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease. Neurology 60(5):790–795
Astrup A, Toubro S et al (1990) Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 51(5):759–767
Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132(6):2131–2157
Baker JA, Beehler GP (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136(1):166–171
Barranco Quintana JL, Allam MF et al (2007) Alzheimer’s disease and coffee: a quantitative review. Neurol Res 29(1):91–95
Battram DS, Graham TE et al (2005) The effect of caffeine on glucose kinetics in humans – influence of adrenaline. J Physiol 569(1):347–355
Battram DS, Arthur R et al (2006) The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 136(5):1276–1280
Battram DS, Graham TE et al (2007a) Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans. J Physiol 583(3):1069–1077
Battram DS, Bugaresti J et al (2007b) Acute caffeine ingestion does not impair glucose tolerance in persons with tetraplegia. J Appl Physiol 102(1):374–381
Belfort R, Mandarino L (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54(6):1640–1648
Bidel S, Hu G et al (2006) Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 49:2618–2626
Boden G, Lebed B et al (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50(7):1612–1617
Bonen A, Megeney LA et al (1992) Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187(2):685–691
Bracco D, Ferrarra JM et al (1995) Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 269(4 Pt 1):E671–E678
Bravi F, Bosetti C et al (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46(2):430–435
Bullock BP, Heller RS et al (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137(7):2968–2978
Buxton DB, Fisher RA et al (1987) Stimulation of glycogenolysis and vasoconstriction by adenosine analogs in the perfused rat liver. Biochem J 248:35–41
Camargo MC, Toledo MC et al (1999) Caffeine daily intake from dietary sources in Brazil. Food Addit Contam 16(2):79–87
Challis RAJ, Budohoski L et al (1984) Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats. Biochem J 221:915–917
Cheng JT, Chi TC et al (2000) Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats. Auton Neurosci 83:127–133
Cornelis MC, El-Sohemy A et al (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295(10):1135–1141
Daly JW, Fredholm BB (2004) Mechanisms of action of caffeine on the nervous system. In: Nehlig A (ed) Coffee, tea, chocolate and the brain, 1st edn. CRC Press, Boca Raton, FL
De Felice FG, Verira MNN et al (2009) Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of A beta oligomers. Proc Natl Acad Sci USA 106:1971–1976
de Galan BE, Tack CE et al (2002) Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51:790–796
Debrah K, Haigh R et al (1995) Effects of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 89(5):475–480
Dekker MJ, Gusba JE et al (2007) Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br J Nutr 98:556–562
Dixon AK, Gubitz AK et al (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118(6):1461–1468
Dresner A, Laurent D et al (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103(2):253–259
Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696–1705
Dulloo AG, Geissler CA et al (1989) Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 49(1):44–50
Engler MB, Engler MM (2006) The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64(3):109–118
Frary CD, Johnson RK, Wang MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105(1):110–113
Fredholm BB, Bättig K et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83–133
Freedman ND, Everhart JE et al (2009) Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50(5):1360–1369
Gallus S, Bertuzzi M et al (2002a) Does coffee protect against hepatocellular carcinoma? Br J Cancer 87:956–959
Gallus S, Tavani A et al (2002b) Does coffee protect against liver cirrhosis? Ann Epidemiol 12(3):202–205
Ganmaa D, Willett WC et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076
Goodman MT, Tung KH et al (2003) Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46(1):23–29
Graham TE, Spriet LL (1995) Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J Appl Physiol 78(3):867–874
Graham TE, Hibbert E et al (1998) Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol 85(3):883–889
Graham TE, Helge JW et al (2000) Caffeine ingestion does not alter carbohydrate of fat metabolism in human skeletal muscle during exercise. J Physiol 529(3):837–847
Graham TE, Sathasivam P et al (2001) (2001) Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol 79:559–565
Greenberg JA, Axen KV et al (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29(9):1121–1129
Greenberg JA, Owen DR et al (2009) Decaffeinated coffee and glucose metabolism in young men. Diabetes Care 33(2):278–280
Greer F, Hudson R et al (2001) Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 50(10):2349–2354
Hallström H, Wolk A et al (2006) Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 17:1055–1064
Hammar N, Andersson T et al (2003) Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J Intern Med 253:653–659
Han XX, Bonen A (1998) Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274(4Pt1):E700–E707
Han DH, Hansen PA et al (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47(11):1671–1675
Harris SS, Dawson-Hugues B (1994) Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 60:573–578
Health Canada (2007) Caffeine. http://www.hc-sc.gc.ca/fn-an/securit/facts-faits/caffeine_e.html. Cited 8 Feb 2010.
Herling AW, Burger H et al (1999) Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 368(1):75–82
Hernan MA, Takkouche B et al (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol 52(3):276–284
Hernandez-Avila M, Colditz GA et al (1991) Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr 54:157–163
Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–123
Hilliare-Buys D, Gross R et al (1989) Effect of pertussis toxin on A1 receptor-mediated inhibition of insulin secretion. Br J Pharmacol 96:3–4
Homko CJ, Cheung P et al (2003) Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 52(2):487–491
Honjo S, Kono S et al (2001) Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 54(8):823–829
Howlett K, Galbo H et al (1999) Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans. J Phys 519(3):911–921
Hu G, Bidel S et al (2007) Coffee and tea consumption and the risk of Parkinson’s disease. Mov Disord 22(15):2242–2248
Hu G, Tuomilehto J et al (2008) Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 48(1):129–136
Huxley R, Lee CMY et al (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. Arch Intern Med 169(22):2053–2063
Ingelman-Sundberg M, Sim SC et al (2006) Coffee, myocardial infarction, and CYP nomenclature. JAMA 296(7):764–765
Inoue M, Yoshimi I et al (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97:293–300
Inoue M, Kurahashi N et al (2009) Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomark Prev 18(6):1746–1753
Ishitani K, Lin J et al (2008) Caffeine consumption and risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168(18):2022–2031
Itani SI, Ruderman NB et al (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(17):2005–2011
Jacobson TL, Febbraio MA et al (2001) Effect of caffeine co-ingested with carbohydrate or fat on metabolism and performance in endurance-trained men. Exp Physiol 86(1):137–144
Je Y, Liu W et al (2009) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 124:1662–1668
Jee SH, He J et al (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33:647–652
Jee SH, He J et al (2001) Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153:353–362
Johansson SM, Yang JN et al (2007) Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid. Acta Physiol (Oxf) 190(1):87–96
Johnston KL, Clifford MN et al (2003) Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78(4):728–733
Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176(1):1–29
Jung RT, Shetty PS et al (1981) Caffeine: its effect on catecholamines and metabolism in lean and obese humans. Clin Sci (Lond) 60(5):527–535
Kabagambe EK, Wellons MF (2009) Benefits and risk of caffeine and caffeinated beverages. In Eamranond P (ed) UpToDate, version 17.3
Kacker S (2003) Ingestion of caffeinated coffee impairs blood glucose homeostasis in response to either high or low glycemic index cereals in non-obese males. Master thesis, University of Guelph
Keijzers GB, DeGalan BE et al (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25:364–369
Kiel DP, Felson DT et al (1990) Caffeine and the risk of hip fracture: the Framingham study. Am J Epidemiol 132:675–684
Kleemola P, Jousilahti P et al (2000) Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160:3393–3400
Korpelainen R, Korpelainen J et al (2003) Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. Osteoporos Int 14(1):34–43
Kotsopoulos J, Ghadiria P et al (2007) The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomark Prev 16(5):912–916
Kruszynska YT, Worrall DS et al (2002) Fatty acid-induced insulin resistance: decreases muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87(1):226–234
Kurozawa Y, Ogimoto I et al (2005) Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93:607–610
La Vecchia C, Tavani A (2007) Coffee and cancer risk: an update. Eur J Cancer Prev 16:385–389
Lane JD, Barkauskas CE et al (2004) Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 27(8):2047–2048
Lane JD, Feinglos MN et al (2008) Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. Diabetes Care 31(2):221–222
Larsson SC, Bergkvist L et al (2006) Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 163:638–644
Lee S, Hudson R et al (2005) Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28(3):566–572
Liang HX, Belardinelli L et al (2002) Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 135(6):1457–1466
Lloyd T, Johnson-Rollings N et al (2000) Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. J Am Coll Nutr 19(2):256–261
Lopez-Garcia E, van Dam RM et al (2006) Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83(3):674–680
Lopez-Garcia E, van Dam RM et al (2008) The relationship of coffee consumption with mortality. Ann Intern Med 148:904–914
Lopez-Garcia E, Rodriguez-Artalejo F et al (2009) Coffee consumption and risk of stroke in women. Circulation 119:1116–1123
Lovallo WR, Wilson MF et al (2004) Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension 43:760–765
Lundsberg LS (1998) Caffeine consumption. In: Spiller JA (ed) Caffeine, 1st edn. CRC Press, Boca Raton, FL
Lynge J, Hellsten Y (2000) Distribution of adenosine A1, A2a and A2b receptors in human skeletal muscle. Acta Physiol Scand 169:283–290
Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer’s disease? Eur J Neurol 9(4):377–382
Martin EA, Nicholson WT et al (2006a) Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. J Appl Physiol 101(2):492–499
Martin EA, Nicholson WT et al (2006b) Influences of adenosine receptor antagonism on vasodilator responses to adenosine and exercise in adenosine responders and nonresponders. J Appl Physiol 101(6):1678–1684
Martin EA, Nicholson WT et al (2007) Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders. J Physiol 59(Pt 1):237–245
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470
McCarthy MF (2005) A chlorogenic acid-induced increase in GLP-1 production may mediate the impacts of heavy coffee consumption on diabetes risk. Med Hypotheses 64:848–853
McLane MP, Black PR et al (1990) Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes 39(1):62–69
McLean C, Graham TE (2002) Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women. J Appl Physiol 93:1471–1478
Meier JJ, Goetze O et al (2004) Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab 286:E621–E625
Michels KB, Willet WC et al (2005) Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 97(4):282–292
Mineharu Y, Koizumi A et al (2009) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health, doi:10.1136/jech.2009.097311
Misra A, Khurana L (2008) Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 93:S9–S30
Mohr T, Van Soeren M et al (1998) Caffein ingestion and metabolic responses of tetraplegic humans during electrical cycling. J Appl Psysiol 85(3):979–985
Moisey LL, Kacker S et al (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87(5):1254–1261
Moisey LL, Robinson LE et al (2009) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 103(6):833–841
Montella M, Polesel J et al (2007) Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120(7):1555–1559
Mukamal KJ, Hallqvist J et al (2009) Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 157:495–501
Naganuma T, Kuriyama S et al (2007) Coffee consumption and risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 120:1542–1547
Nawrot P, Jordan S et al (2003) Effects of caffeine on human health. Food Addit Contam 20(1):1–30
Nkondjock A, Ghadirian P et al (2006) Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 118(1):103–107
Norager CB, Jensen MB et al (2006) Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol 65:223–228
Nygard O, Refsum H et al (1997) Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 65:136–143
Olmos V, Bardoni N et al (2009) Caffeine levels in beverages from Argentina’s market: application to caffeine dietary intake assessment. Food Addit Contam A Chem Anal Control Expos Risk Assess 26(3):275–281
Palatini P, Ceolotto G et al (2009) CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens 27(8):1594–1601
Pelluchi C, La Vecchia C (2009) Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. Eur J Cancer Prev 18(1):62–68
Pencek RR, Battram D et al (2004) Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs. J Nutr 134(11):3042–3046
Pereira MA, Parker ED et al (2006) Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166(12):1311–1316
Petrie HJ, Chown SE et al (2004) Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 80(1):22–28
Pizziol A, Tikhonoff V et al (1998) Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 52(11):846–849, Abstract
Quinlan PT, Lane J et al (2000) The acute physiological and mood effects of tea and coffee: the role of caffeine level. Pharmacol Biochem Behav 66(1):19–28
Ranheim T, Halvorsen B (2005) Coffee consumption and human health – beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 49:274–284
Rapuri PB, Gallagher C et al (2001) Caffeine intake increases the rate of bone lose in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74:694–700
Reissig CJ, Strain ED et al (2009) Caffeinated energy drinks – a growing problem. Drug Alcohol Depend 99(1–3):1–10
Reppert SM, Weaver DR (1991) Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 5(8):1037–1048
Ricksen NP, Rongen GA et al (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121(2):185–191
Riksen NP, Smits P et al (2010) The cardiovascular effects of methylxanthines. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
Robinson LE, Spafford et al (2009) Acute caffeine-induced impairment in insulin sensitivity in women with gestational diabetes mellitus. J Obstet Gynacol Can 31:304–312
Robertson D, Wade D et al (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67(4):1111–1117
Robinson LE, Savani S et al (2004) Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 134(10):2528–2533
Rosner SA, Akesson A et al (2006) Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol 165:288–293
Ruhl CE, Everhart JE (2005a) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128(1):24–32
Ruhl CE, Everhart JE (2005b) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129(6):1928–1936
Rush JW, Spriet LL (2001) Skeletal muscle glycogen phosphorylase a kinetics: effects of adenine nucleotides and caffeine. J Appl Physiol 91(5):2071–2078
Salazar-Martinez E, Willet WC et al (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140(1):1–8
Sandhu H, Wiesenthal SR et al (1999) Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes 48(5):1045–1053
Sasaki H, Takaoka I et al (1987) Effects of sucrose or caffeine ingestion on running performance and biochemical responses to endurance running. Int J Sports Med 8(3):203–207
Sawynok J (2010) Methylxanthines and pain. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15(9):813–827
Shearer J, Farah A et al (2003) Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 133(11):3529–3532
Shearer J, Sellars EA et al (2007) Effects of chronic coffee consumption on glucose kinetics in the conscious rat. Can J Physiol Pharmacol 85:823–830
Shimazu T, Tsuborno Y et al (2005) Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116(1):150–154
Silletta MG, Marfisi RM et al (2007) Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSS (Gruppo italiano per lo studio della sopravvievenza nell’infarto miocardico) – prevenzione trial. Circulation 116:2944–2951
Smith B, Wingard DL et al (2006) Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose? Diabetes Care 29:2385–2390
Smits P, Hoffmann H et al (1983) Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade. Clin Pharmacol Ther 34(2):153–158
Smits P, Lenders JW et al (1990) Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther 48(4):410–418
Smits P, Stratman C et al (1991) Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther 50(5 Pt 1):529–537
Stamler J, Vaccaro O et al (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2):434–444
Tan EK, Tan C et al (2003) Dose-dependent protective effects of coffee, tea, and smoking in Parkinson’s disease: a study in ethnic Chinese. J Neurol Sci 216(1):163–167
Tanaka K, Hara M et al (2007) Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 98(2):214–218
Thom E (2007) The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res 35:900–908
Thong FSL, Graham TE (2002) Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 92(6):2347–2352
Thong FSL, Derave W et al (2002) Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51(3):583–590
Thong FS, Lally JS et al (2007) Activation of the A1 adenosine receptor increases insulin-stimulated glucose transport in isolated rat soleus muscle. Appl Physiol Nutr Metab 32(4):701–710
Töpfer M, Burbeil CE et al (2008) Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca+ uptake. Cell Biochem Funct 26:833–843
Tse SYH (1991) Coffee contains cholinomimetic compound distinct from caffeine. 1: purification and chromatographic analysis. J Pharm Sci 80:665–669
Tse SYH (1992) Cholinomimetic compound distinct from caffeine contained in coffee. II: Muscarinic actions. J Pharm Sci 81:449–452
Tunicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290–1300
Tunicliffe JM, Erdman KA et al (2008) Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab 33:1301–1310
Tuomilehto J, Hu G et al (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291(10):1213–1219
van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular disease, and cancer. Appl Physiol Nutr Metab 33:1269–1283
van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294(1):97–104
van Dam RM, Willett WC et al (2006) Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care 29(2):398–403
van Dijk AE, Olthof MR et al (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025
Van Dusseldorp M, Katan MB et al (1991) Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb Vasc Biol 11:586–593
Van Nieuwenhoven MA, Brummer RM et al (2000) Gastrointestinal function during exercise: comparison of water, sports drink, and sports drink with caffeine. J Appl Physiol 89(3):1079–1085
Van Soeren MH, Nohr T et al (1996) Acute effects of caffeine ingestion at rest in humans with impaired epinephrine responses. J Appl Physiol 80:999–1005
Van Soeren MH, Sathasivam P et al (1993) Caffeine metabolism and epinephrine responses during exercise in users and nonusers. J Appl Physiol 75(2):805–812
Vergauwen L, Hespel P et al (1994) Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93:974–981
Vergauwen L, Richter EA et al (1997) Adenosine exerts a glycogen-sparing action in contracting rat skeletal muscle. Am J Physiol 272(5Pt1):E762–E768
Villanueva CM, Silverman DT et al (2009) Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 20(1):121–127
Wei Y, Mojsov S (1996) Distribution of GLP-1 and PACAP receptors in human tissues. Acta Physiol Scand 157(3):355–357
World Health Organization (2010) Diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/print.html. Accessed 10 Feb 2010
Wu T, Willet WC et al (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28:1390–1396
Yamada M, Sasaki S et al (2009) Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations. Public Health Nutr 16:1–10
Yeo SE, Jentjens RL et al (2005) Caffeine increases exogenous carbohydrate oxidation during exercise. J Appl Physiol 99(3):844–850
Zeegers MP, Tan FE et al (2001) Are coffee and tea consumption associated with urinary tract cancer risk? Int J Epidemiol 30(2):353–362
Zhang WL, Lopez-Garcia E et al (2009) Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 52:810–817
Acknowledgements
The work by the authors was supported by the Natural Science and Engineering Research Council of Canada (NSERC). M.-S.B. received an Ontario Graduate Scholarship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Beaudoin, MS., Graham, T.E. (2011). Methylxanthines and Human Health: Epidemiological and Experimental Evidence. In: Methylxanthines. Handbook of Experimental Pharmacology, vol 200. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13443-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-13443-2_21
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13442-5
Online ISBN: 978-3-642-13443-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)